Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-17, Stock:ABT, The news for the past five days is as follows:
2020-06-10: nan
2020-06-11: NEWS1: Diagnostic Testing Remains Crucial in Combatting Coronavirus.NEWS2: Abbott Labs Stock Falls 3%.NEWS3: INSIGHT-Europe sets sights on dud antibody tests amid COVID-19 free-for-all.
2020-06-12: NEWS1: Abbott (ABT) Outpaces Stock Market Gains: What You Should Know.NEWS2: Abbott Declares 386th Consecutive Quarterly Dividend.NEWS3: 3 Diabetes Management Stocks in the Spotlight Amid Coronavirus.
2020-06-15: NEWS1: Abbott Gains FDA Nod For A New Diabetes Device, But Dexcom Rockets.NEWS2: Abbott Gains New Clearance As Devices Rivalry With Dexcom Builds.NEWS3: Is Abbott Stock A Buy As Worries Of A Second Coronavirus Wave Spread?.NEWS4: FDA clears new version of Abbott's diabetes glucose monitor.NEWS5: Abbott's (ABT) FreeStyle Libre Study Outcome Favorable.NEWS6: Abbott's Bluetooth-Enabled Glucose Monitor Finally Clears FDA Hurdle.NEWS7: Abbott's Bluetooth-Enabled Glucose Monitor Finally Clears FDA Hurdle.NEWS8: U.S. FDA clears new version of Abbott's low-cost glucose monitor.NEWS9: U.S. FDA clears version 2.0 of Abbott's low-cost glucose monitor.NEWS10: Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards.
2020-06-16: NEWS1: Abbott's Libre 2 iCGM Gets FDA Nod to Better Manage Diabetes.NEWS2: New Data Show Use of Abbott's FreeStyle® Libre System Reduces All-Cause, Diabetic Ketoacidosis-Related Hospitalization Rates and Acute Diabetes Events.NEWS3: New Data Show Use of Abbott's FreeStyle® Libre System Reduces All-Cause, Diabetic Ketoacidosis-Related Hospitalization Rates and Acute Diabetes Events.NEWS4: FOCUS-U.S. health insurers may balk at paying for coronavirus antibody testing.NEWS5: UK antibody test access stokes frustration and confusion.NEWS6: Delay and confusion about finding a reliable antibody test in the UK.

Answer: Rise